先健科技(1302.HK)漲超5%創逾3個月新高
格隆匯5月24日丨先健科技(1302.HK)近期持續走強,今日漲勢繼續,盤中一度漲5.62%報4.89港元,股價創逾3個月新高,市值超220億港元;該股在本月迎來多個利好消息,月內股價累漲16%。

5月12日,公司宣佈旗下控股子公司先健呼吸科技自主研發的Cinenses™肺減容回力圈系統已順利完成歐洲臨牀試驗入組,標誌着先健科技已堅實地邁入呼吸疾病介入診斷治療這一廣闊新領域。
5月17日,公司宣佈旗下創新產品G-Branch™胸腹主動脈覆膜支架系統的FIM研究已完成全部患者入組,且中期隨訪結果表現優秀,標誌着該創新產品在商業化上邁出了非常關鍵的一步。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.